Maggie
Maggie is 68 and is a retired paediatric nurse. She is married with two adult children who are 34 and 43. Ethnicity: white British
Maggie found out about MND in her family when her brother was diagnosed, 30 years after their mum developed symptoms. Although she was initially reluctant to pursue genetic testing, she recently found out that she does not carry the C9orf72 gene variant.
When Maggie’s mother was diagnosed with MND in her late 60s, Maggie became her full-time carer, a time she describes as an emotional rollercoaste. Although at the time they were told that it would not affect other members of the family, in 2018 her brother John developed problems with his leg. Initially, they did not consider MND, but a MND diagnosis was confirmed after further tests. Because of the family history, John had genetic testing and was found to carry the C9orf72 gene variant. After his diagnosis, Maggie spent several days a month with him, providing respite to his partner. John died in April 2020, and although adapting to life without her brother is difficult, Maggie values the time they spent together. Since then, another of their brothers has been diagnosed with frontotemporal dementia, caused by the C9orf72 gene, and doctors are investigating whether he could also have MND.
After John’s diagnosis, the focus was on supporting him. However, Maggie started to consider the implications for herself and her children. Initially, she had a sense that she did not want to know her genetic status, as there’s nothing I can do about i. She felt that she would rather live with a 50/5 chance than a positive result. However, Maggie’s views on pre-symptomatic genetic testing changed over the two years since finding out about MND in the family. There were periods where she thought she had symptoms, and started to question whether she could be worrying unnecessarily. She also found out about clinical trials targeting the C9orf72 gene and felt that knowing her genetic status may help her identify symptoms early and possibly join a trial sooner. Maggie knew that her daughter, Kirsty, had also considered genetic testing. She had not pursued this further as she did not want her own result to reveal Maggie’s, which could happen if she were to test positive.
In 2020, Maggie went to her GP and was referred to genetic counselling to start the testing process. She had a phone conversation with a genetic counsellor, who was satisfied that she had considered her decision and the implications. She sent her a blood form in the post, so that Maggie could have the blood test at her local GP surgery.
When the phone call came with the results, Maggie was told that it’s good new. She was taken aback; she hadn’t allowed herself to imagine that she might receive a negative result. She was pleased to be able to tell family, particularly after having worried about needing to share the news of a positive result and its implications for her children.
Although Maggie feels relief over not having inherited the gene variant, she emphasises that MND has not gone away; there is still a sadness over the loss of John and their other brother’s illness, and practical things to sort out around organising their affairs. However, the horizons have opened up a bit mor, and Maggie is grateful to think that the family life she enjoys can continue for longer. She doesn’t need to consider issues like moving to a more accessible home, and no longer worries about things like tripping over. Maggie believes that the decision she made over genetic testing was right for her; her siblings have taken different approaches, and she maintains that there is no right or wron.
Maggie and her siblings have all been involved in research around MND, which has involved having various tests including a lumbar puncture and an MRI scan. Maggie hopes that this research will lead to progress in finding a treatment or a cure in the future.